Nintedanib Esylate
Who holds supplier records for Nintedanib Esylate? 19 organisations hold a current record for Nintedanib Esylate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (8), China (5), Finland (1), Taiwan (1) and 3 other countries (3); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Nintedanib Esylate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/nintedanib-esylate
Reading the evidence
- 19 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 12 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (19)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Nintedanib Esylate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTDChinaActive DMF 44101, 40620 · latest filing Jun 2026
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 32152 · latest filing Dec 2017
- BDR LIFESCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 40208 · latest filing Sept 2024
- Biocon LimitedIndiaActive DMF 41354 · latest filing Mar 2025
- CHEMO IBERICA SAActive DMF 39158 · latest filing Nov 2023
- Cipla LimitedIndia Company GMP cert on recordActive DMF 32504 · latest filing Mar 2018
- FERMION OYFinland Company GMP cert on recordActive DMF 33361 · latest filing Jan 2019
- Formosa Laboratories, Inc.Taiwan Company GMP cert on recordActive DMF 32643 · latest filing Apr 2018
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 35582 · latest filing Jan 2021
- HUBEI CHENGTIAN PHARMACEUTICAL CO LTDChinaActive DMF 33152 · latest filing Sept 2018
- Jiangsu Hansoh Pharmaceutical Group Company LimitedChina Company GMP cert on recordActive DMF 34332 · latest filing Dec 2019
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 38606 · latest filing Mar 2024
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 31526 · latest filing Mar 2017
- OLON SPAItaly Company GMP cert on recordActive DMF 32529 · latest filing Feb 2018
- Shandong Anhong Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 38298 · latest filing Apr 2023
- Sichuan Kelun Pharmaceutical Co., Ltd.ChinaActive DMF 37986 · latest filing Mar 2023
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 32866 · latest filing Aug 2018
- TAPI NL BVNetherlandsActive DMF 37872 · latest filing Dec 2022
- VERANOVA LPUnited KingdomActive DMF 32511 · latest filing Mar 2018
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Nintedanib Esylate is a tyrosine kinase inhibitor used in the treatment of idiopathic pulmonary fibrosis and certain types of non-small cell lung cancer. It inhibits multiple receptor pathways, leading to reduced tumor angiogenesis and fibrosis.
Chemical identity
- IUPAC name
- ethanesulfonic acid;methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylate
- Canonical SMILES
- CCS(=O)(=O)O.CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N/C(=C\3/C4=C(C=C(C=C4)C(=O)OC)NC3=O)/C5=CC=CC=C5
- InChIKey
- MMMVNAGRWOJNMW-FJBFXRHMSA-N
- Synonyms
- Ofev API, nintedanib esilate, nintedanib ethanesulfonate, ofev
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Kinase Inhibitor
- Mechanism of action
- Protein Kinase Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Nintedanib Esylate?
19 organisations hold an active US FDA Type II Drug Master File or a CEP for Nintedanib Esylate: CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD (China), ALIVUS LIFE SCIENCES LTD (India), BDR LIFESCIENCES PRIVATE LIMITED (India), Biocon Limited (India), CHEMO IBERICA SA, Cipla Limited (India), FERMION OY (Finland) and Formosa Laboratories, Inc. (Taiwan), and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Nintedanib Esylate Drug Master Files are active?
CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD (DMF 44101, 40620), ALIVUS LIFE SCIENCES LTD (DMF 32152), BDR LIFESCIENCES PRIVATE LIMITED (DMF 40208), Biocon Limited (DMF 41354), CHEMO IBERICA SA (DMF 39158), Cipla Limited (DMF 32504), FERMION OY (DMF 33361) and Formosa Laboratories, Inc. (DMF 32643) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Nintedanib Esylate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Nintedanib Esylate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.